GAIA vs CURI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

GAIA

44.3
AI Score
VS
GAIA Wins

CURI

25.7
AI Score

Investment Advisor Scores

GAIA

44score
Recommendation
HOLD

CURI

26score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GAIA CURI Winner
Revenue 47.64M 15.16M GAIA
Net Income -4.28M -1.33M CURI
Net Margin -9.0% -8.8% CURI
Operating Income -4.64M -1.54M CURI
ROE -5.1% -3.6% CURI
ROA -2.9% -1.9% CURI
Total Assets 147.69M 69.16M GAIA
Cash 5.27M 16.90M CURI
Current Ratio 0.41 0.95 CURI

Relative Price Performance (Last 90 Days)

GAIA 1M: -41.8% · 3M: -51.8% CURI 1M: +7.7% · 3M: -7.6%

Current Technical Phase

GAIA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.8%), weak momentum, RSI 15

RSI (14): 15.3 · Price: $1.21

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 62.5 · Price: $2.81

Fundamentals Snapshot

Metric GAIA CURI
Market Cap
Forward P/E -5.3 11.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.9% 0.6%
Operating Margin -0.1% -0.1%
EPS -0.19 -0.14
Dividend Yield 0.11%

Frequently Asked Questions

Based on our detailed analysis, GAIA is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.